1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
EFTA00520767
ving gadolinium may develop a headache or experience mild nausea. Rarely, local Inflammation may occur at the Injection site. O I CONSENT to having Gadolinium contrast as needed. (Check box if you agree to contrast) O I DECLINE having a Gadolinium contrast injection at this time. (Check box if you disagree
No connected entities